Evidence map›Paper›PMID 20959530›Full record

Trial reportAmerican journal of physiology. Endocrinology and metabolism2011

Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.

Kevin E Yarasheski, W Todd Cade, E Turner Overton, Kristin E Mondy, Sara Hubert, Erin Laciny, Coco Bopp, Sherry Lassa-Claxton, Dominic N Reeds

2 registry-linked trialsAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of physiology. Endocrinology and metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00639457 nacompletednot on this map

Exercise and Pioglitazone for HIV-Metabolic Syndromes

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2005 to 2009Enrolled44ConditionsHIV Infections, Type 2 Diabetes, Obesity, HIVArmsPioglitazone, Exercise training
NCT00656851 nacompletednot on this map

Myocardial Function, Free Fatty Acid and Glucose Metabolism in HIV Metabolic Syndrome

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2005 to 2010Enrolled24ConditionsHIV Infections, Cardiovascular Disease, Insulin Resistance, HIV LipodystrophyArmsPioglitazone, Exercise Training
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Diabetes in People with HIV.Current diabetes reports · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kevin E YarasheskiDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. key@wustl.edu
W Todd Cade
E Turner Overton
Kristin E Mondy
Sara Hubert
Erin Laciny
Coco Bopp
Sherry Lassa-Claxton
Dominic N Reeds
Washington University in St. Louis · US

Funding

Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI NEWCOMER, JOHN W. · 1985 to 2007
$25.4M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 1985 to 2011
$16.0M
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNITU01AI069495 · NIAID · WASHINGTON UNIVERSITY · PI CLIFFORD, DAVID B · 2007 to 2011
$7.7M
Myocardial Function /FFA Metabolism in HIV Metabolic SynR01DK059531 · NIDDK · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2000 to 2008
$3.8M
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNITUM1AI069495 · NIAID · WASHINGTON UNIVERSITY · PI CLIFFORD, DAVID B · 2012 to 2013
$2.9M
PROTEIN TURNOVER AND ANABOLIC INTERVENTIONS IN AIDSR01DK049393 · NIDDK · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 1994 to 2008
$2.2M
Yoga for the Management of HIV-Metabolic SyndromesR21AT003083 · NCCIH · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2005 to 2007
$604k
NCATS NIH HHS UL1 TR000448NCCIH NIH HHS R21 AT003083NCRR NIH HHS M01 RR000036NCRR NIH HHS P41 RR000954NCRR NIH HHS RR-000954NCRR NIH HHS RR-019508NCRR NIH HHS RR-024992NIAID NIH HHS AI-065336NIAID NIH HHS AI-069495NIDDK NIH HHS DK-020579NIDDK NIH HHS DK-049393NIDDK NIH HHS DK-056341NIDDK NIH HHS DK-059531NIDDK NIH HHS DK-074343NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK049393NIDDK NIH HHS R01 DK059531NIDDK NIH HHS R21 DK074345NIDDK NIH HHS R56 DK049393
6 · The paper itself

Abstract

The prevalence and incidence of insulin resistance and type 2 diabetes mellitus (DM) are higher in people treated for human immunodeficiency virus-1 (HIV) infection than in the general population. Identifying safe and effective interventions is a high priority. We evaluated whether the peroxisome proliferator-activated receptor-γ agonist pioglitazone with exercise training improves central and peripheral insulin sensitivity more than pioglitazone alone in HIV-infected adults with insulin resistance and central adiposity. Forty-four HIV-infected adults with baseline insulin resistance and central adiposity were randomly assigned to 4 mo of pioglitazone (30 mg/day) with or without supervised, progressive aerobic, and resistance exercise training (1.5-2 h/day, 3 days/wk). The hyperinsulinemic euglycemic clamp was used to evaluate alterations in central and peripheral insulin sensitivity. Thirty-nine participants completed the study. Hepatic insulin sensitivity improved similarly in both groups. Exercise training augmented the beneficial effects of pioglitazone on peripheral insulin sensitivity. Greater improvements in peripheral insulin sensitivity were associated with reductions in total body and limb adipose content rather than increases in limb adiposity or pioglitazone-induced increases in adiponectin concentration. We conclude that supplementing pioglitazone with increased physical activity improved insulin sensitivity more effectively than pioglitazone alone in HIV-infected adults with insulin resistance and central adiposity. Pioglitazone alone did not significantly increase limb adipose content. Potential cardiovascular benefits of these interventions in HIV need investigation.

Indexed as

AdiposityAdolescentAdultCombined Modality TherapyDiabetes Mellitus, Type 2ExerciseFemaleGlucose Clamp TechniqueHIV InfectionsHumansHypoglycemic AgentsInsulin ResistanceLiverMaleMiddle AgedObesity, AbdominalHypoglycemic AgentsPioglitazonePPAR gammaThiazolidinediones

Identifiers

PMID20959530
PMCPMC3023206
OpenAlexW2137968126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.